tyrosine has been researched along with Coronary Thrombosis in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (14.49) | 18.2507 |
2000's | 35 (50.72) | 29.6817 |
2010's | 23 (33.33) | 24.3611 |
2020's | 1 (1.45) | 2.80 |
Authors | Studies |
---|---|
Batta, A; Bhogal, S; Gupta, H; Jaiswal, B; Mehrotra, S; Panda, P; Rambabu, E; Sharma, YP | 1 |
Dong, P; Li, Z; Liu, X; Wang, H; Wang, S; Xing, S; Yang, X; Zhai, Q; Zhang, H | 1 |
Aytekin, V; Karabay, KO; Yildiz, O | 1 |
Du, J; Li, W; Liu, Y; Ni, Z; Wang, H; Wang, L; Xia, K; Xu, L; Yang, X; Zhang, D | 1 |
Akpek, M; Arinc, H; Baktir, AO; Ergin, A; Kaya, MG; Oguzhan, A; Saglam, H; Sahin, O; Sarli, B; Urkmez, S | 1 |
Dong, PS; Han, YH; Lai, LH; Wang, HL; Xing, SY; Zhao, JF; Zhu, JH | 1 |
Ding, FH; Du, R; Hu, J; Liao, ML; Shen, WF; Wang, XL; Yang, ZK; Zhang, JS; Zhang, Q; Zhang, RY; Zhu, TQ | 1 |
Han, Y; Li, Y; Liang, Z; Liu, H; Ma, L; Stone, GW; Wang, D; Wang, J; Wang, S; Yang, L | 1 |
Borklu, EB; Cinier, G; Eren, M; Hayiroglu, MI; Kaya, A; Keskin, M; Tatlisu, MA; Uzman, O | 1 |
Abreu-Gonzalez, P; Avanzas, P; Conesa-Zamora, P; Consuegra-Sanchez, L; Dominguez-Rodriguez, A; Sanchez-Grande, A | 1 |
Bahia, A; Fry, J; Naqvi, A; Seto, A | 1 |
Acar, G; Nacar, AB; Sökmen, G; Tuncer, C | 1 |
Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH | 1 |
Simsek, V; Timurkaynak, T; Turkoglu, S | 1 |
Biondi-Zoccai, G; Lotrionte, M; Sheiban, I | 1 |
Giannitsis, E; Ivandic, BT; Katus, HA; Keck, F; Kurz, K; Lehrke, S; Staritz, P | 1 |
Duran, NE; Kocabay, G; Ozkan, M; Yildiz, M | 1 |
Angiolillo, DJ; Brugaletta, S; Campo, G; Colangelo, S; de Cesare, N; Ferrari, R; Furgieri, A; Hamon, M; Meliga, E; Parrinello, G; Percoco, G; Repetto, A; Sabatè, M; Valgimigli, M; Vranckx, P | 1 |
De Boer, MJ; Dill, T; Gosselink, AT; Hamm, C; Heestermans, AA; Hoorntje, JC; Koopmans, PC; Ten Berg, JM; Van 't Hof, AW; Van Houwelingen, G; Van Werkum, JW | 1 |
Akdemir, R; Cagirci, G; Karakurt, O; Kilic, H | 1 |
Barlocco, F; Caracciolo, M; D'Urbano, M; De Servi, S; Klugmann, S; Mariani, G; Nichelatti, M; Savonitto, S | 1 |
Erden, I; Ordu, S; Ozhan, H | 1 |
Cakici, M; Davutoglu, V; Ercan, S; Sari, I; Yuce, M | 1 |
Chi, YP; Li, QX; Li, SY; Li, WZ; Song, L; Wang, J; Wu, Z; Yan, HB; Zhang, XJ; Zhao, HJ; Zheng, B | 1 |
Chiu, YW; Hsu, CN; Hung, CS; Kao, HL; Lee, JK; Lin, MS; Liu, CP | 1 |
Chi, YP; Li, QX; Li, SY; Li, WZ; Liu, C; Song, L; Wang, J; Wu, Z; Yan, HB; Zhang, XJ; Zhao, HJ; Zheng, B | 1 |
Atalar, E; Canpolat, U; Sunman, H; Yorgun, H | 1 |
Breet, NJ; Dambrink, JH; Gosselink, AT; Hamm, C; Hermanides, RS; Ottervanger, JP; ten Berg, JM; van 't Hof, AW; van Houwelingen, KG; van Werkum, JW | 1 |
Berger, A; Freeman, A | 1 |
Kern, MJ; Seto, A | 1 |
Bayır, PT; Duyuler, S; Topaloğlu, S; Uygur, B | 1 |
Akpinar, I; Aydin, M; Cil, C; Dogan, SM; Karabag, T; Sayin, MR | 1 |
Coner, A; Müderrisoğlu, H; Okyay, K; Yıldırır, A | 1 |
Carter, AJ; DiBattiste, PM; Fearon, WF; Herity, NA; Hiatt, BL; Huston, M; Lee, DP; Rezaee, M; Schreiber, D; Yeung, AC | 1 |
Brown, DL; Green, SJ; Kaplan, RC; Ravi, KL; Sanborn, TA; Sherman, W; Slater, JN; Vakili, BA | 1 |
Akdemir, R; Uyan, C | 1 |
Chang, HW; Chen, MC; Chen, SM; Fang, CY; Hsieh, YK; Wu, CJ; Yip, HK | 1 |
Chang, HW; Chen, CJ; Chen, SM; Cheng, CI; Fang, CY; Hsieh, YK; Hung, WC; Wu, CJ; Yang, CH; Yip, HK | 1 |
Chang, HW; Chen, CJ; Chen, MC; Chen, SM; Cheng, CI; Hung, WC; Kuo, FY; Wu, CJ; Yang, CH; Yip, HK | 1 |
Aydin, M; Bilge, M; Ozeren, A; Ozkökeli, M; Unalacak, M | 1 |
Koehler, B; Meyners, W; Peters, S; Trümmel, M | 1 |
Barcin, C; Iyisoy, A; Kursaklioglu, H | 1 |
Cannizzaro, S; Di Pasquale, P; Paterna, S | 1 |
Goodman, CN; Kaul, S; Klibanov, AL; Lindner, JR; Sakuma, T; Sari, I | 1 |
Barutcu, I; Boztosun, B; Gunes, Y; Kirma, C | 1 |
Cengel, A; Taçoy, G; Timurkaynak, T; Yalçin, R | 1 |
Cay, S; Korkmaz, S; Topaloğlu, S | 1 |
Münzel, TF; Post, F | 1 |
Augoustides, JG | 1 |
Atmaca, Y; Erol, C; Ozdol, C | 1 |
Arslan, U; Balcioglu, S; Timurkaynak, T; Turkoglu, S | 1 |
Fitzgerald, DJ; Murphy, NP; Pratico, D | 1 |
Colombo, A; Dangas, G | 1 |
Harrington, RA | 1 |
Juran, NB | 1 |
Dyke, CM | 1 |
Sax, FL; Snapinn, SM; Théroux, P; Zhao, XQ | 1 |
Bhatia, D; Dyke, C | 1 |
Farmer, JA; Frangogiannis, NG; Lakkis, NM | 1 |
Cohen, M | 1 |
Ikeda, Y | 1 |
Kurz, HI; Lasala, JM; Taniuchi, M | 1 |
Cemri, M; Cengel, A; Dörtlemez, O; Ozdemir, M; Timurkaynak, T; Yalçin, R | 1 |
Caputo, RP; Esente, P; Giambartolomei, A; Reger, M; Simons, A; Wagner, S | 1 |
Caglar, N; Dagdelen, S; Ergelen, M; Soydinc, S | 1 |
Haramaki, N; Ikeda, H; Imaizumi, T; Kanaya, S; Murohara, T | 1 |
Bickel, C; Fallen, H; Henkel, B | 1 |
Kereiakes, DJ; Young, JJ | 1 |
8 review(s) available for tyrosine and Coronary Thrombosis
Article | Year |
---|---|
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Thrombosis; Diabetes Complications; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Troponin; Tyrosine | 2006 |
Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Thrombosis; Eptifibatide; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Tyrosine | 1999 |
Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes.
Topics: Acute Disease; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 1999 |
Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy.
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Catheterization, Peripheral; Coronary Disease; Coronary Thrombosis; Eptifibatide; Femoral Artery; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 1999 |
Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
Topics: Abciximab; Acute Disease; Antibodies, Monoclonal; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Incidence; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Safety; Tirofiban; Tyrosine | 1999 |
Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon.
Topics: Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Thrombosis; Dose-Response Relationship, Drug; Emergencies; Eptifibatide; Hemostasis, Surgical; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine | 1999 |
Treatment of unstable angina: the role of platelet inhibitors and anticoagulants.
Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Thrombosis; Endothelium, Vascular; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Tyrosine | 1999 |
[GPIIb/IIIa inhibitor].
Topics: Abciximab; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Thrombosis; Drug Design; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2000 |
19 trial(s) available for tyrosine and Coronary Thrombosis
Article | Year |
---|---|
[Efficacité du tirofiban intracoronaire avant pose d'un stent suivi d'une perfusion dans une charge de thrombus importante prouvée par angiographie : une étude randomisée].
Topics: Angiography; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Humans; Percutaneous Coronary Intervention; Perfusion; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
Clinical evaluation of thrombus aspiration combined with tirofiban in patients with acute myocardial infarction with elective percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Echocardiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Radiography; Suction; Tirofiban; Treatment Outcome; Tyrosine | 2013 |
[Effect of intracoronary tirofiban combined with nitroprusside injection through thrombus aspiration catheter during primary percutaneous coronary intervention on acute anterior myocardial infarction patients with heavy thrombosis burden].
Topics: Aged; Cardiac Catheters; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Percutaneous Coronary Intervention; Prognosis; Suction; Tirofiban; Tyrosine | 2014 |
Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Topics: Aged; Coronary Circulation; Coronary Thrombosis; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Time Factors; Tirofiban; Treatment Outcome; Turkey; Tyrosine | 2015 |
Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Topics: Coronary Thrombosis; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Tirofiban; Tyrosine | 2014 |
Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Topics: Aged; Biomarkers; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Up-Regulation | 2015 |
The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.
Topics: Aged; Anticoagulants; Antithrombins; Chi-Square Distribution; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Emergency Treatment; Female; Hemorrhage; Heparin; Hirudins; Humans; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Protective Factors; Recombinant Proteins; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Necrosis; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2008 |
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Sho
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Drug Resistance; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Tirofiban; Tyrosine | 2009 |
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Emergency Medical Services; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombolytic Therapy; Ticlopidine; Tirofiban; Tyrosine | 2009 |
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Loss, Surgical; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug-Eluting Stents; Emergencies; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Perioperative Care; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Substance Withdrawal Syndrome; Ticlopidine; Tirofiban; Tyrosine | 2010 |
Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Electrocardiography; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Suction; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Additive benefit of glycoprotein IIb/IIIa inhibition and adjunctive thrombus aspiration during primary coronary intervention: results of the Initial Thrombosuction and Tirofiban Infusion (ITTI) trial.
Topics: Adult; Aged; Combined Modality Therapy; Coronary Thrombosis; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Suction; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency | 2012 |
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial.
Topics: Angioplasty, Balloon, Coronary; Chemotherapy, Adjuvant; Coronary Angiography; Coronary Thrombosis; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIb-IX Complex; Premedication; Recurrence; Stents; Survival Rate; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Bypass; Coronary Thrombosis; Double-Blind Method; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIb-IX Complex; Postoperative Complications; Retreatment; Time Factors; Tirofiban; Tyrosine | 1997 |
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome managemen
Topics: Aged; Angina, Unstable; Anticoagulants; Arteriosclerosis; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 1999 |
Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population.
Topics: Abciximab; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Thrombosis; Eptifibatide; Exanthema; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Neutropenia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2001 |
42 other study(ies) available for tyrosine and Coronary Thrombosis
Article | Year |
---|---|
Multiple coronary thrombi with cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Coronary Thrombosis; Etoposide; Humans; Male; Percutaneous Coronary Intervention; Stents; Teratoma; Testicular Neoplasms; Tirofiban; Treatment Outcome; Tyrosine | 2014 |
The association of the coronary thrombus burden with all-cause mortality and major cardiac events in ST-segment elevation myocardial infarction patients treated with tirofiban.
Topics: Aged; Cause of Death; Coronary Thrombosis; Female; Hemorrhage; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Thrombus Aspirated from Patients with ST-Elevation Myocardial Infarction: Association between 3-Nitrotyrosine and Inflammatory Markers - Insights from ARTERIA Study.
Topics: Aged; Biomarkers; C-Reactive Protein; CD40 Ligand; Coronary Thrombosis; Enzyme-Linked Immunosorbent Assay; Female; Hemoglobins; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Percutaneous Coronary Intervention; Tyrosine; Vascular Cell Adhesion Molecule-1 | 2016 |
Aspiration thrombectomy and intracoronary tirofiban via GuideLiner
Topics: Cardiac Catheterization; Chemotherapy, Adjuvant; Coronary Angiography; Coronary Thrombosis; Fibrinolytic Agents; Humans; Male; Mechanical Thrombolysis; Middle Aged; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Efficient tirofiban infusion resulting in resolution of intracoronary thrombus.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Fibrinolytic Agents; Heptanoic Acids; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Tirofiban; Tyrosine | 2008 |
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right | 2008 |
Intracoronary thrombus aspiration through a guiding catheter in a case with stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Suction; Tirofiban; Tyrosine | 2008 |
Overcoming "resistance" to aspirin and clopidogrel with tirofiban: fact or fiction?
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Tyrosine | 2008 |
Acute inferior myocardial infarction due to cannabis smoking in a young man.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Fibrinolytic Agents; Humans; Male; Marijuana Smoking; Myocardial Infarction; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Resolution of late sirolimus-eluting stent thrombosis after tirofiban treatment.
Topics: Adult; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Male; Sirolimus; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
A case of acute stent thrombosis treated successfully with intracoronary tirofiban.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Equipment Failure Analysis; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Male; Middle Aged; Shock, Cardiogenic; Stents; Tirofiban; Tyrosine | 2010 |
Complete thrombus resolution with tirofiban in obstructive mechanical prosthetic mitral valve thrombosis.
Topics: Adult; Anticoagulants; Coronary Thrombosis; Echocardiography, Transesophageal; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Tirofiban; Tyrosine; Warfarin | 2010 |
[Efficiency and safety of thrombus aspiration plus intra-infarct-related artery administration of tirofiban during primary angioplasty].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Tirofiban; Tyrosine | 2010 |
Acute stent thrombosis during percutaneous coronary intervention. Treatment with tirofiban.
Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Coronary Thrombosis; Fibrinolytic Agents; Humans; Male; Middle Aged; Radiography; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
Imaging of left main coronary artery thrombus with CT coronary angiography.
Topics: Acute Coronary Syndrome; Anticoagulants; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Echocardiography; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Tirofiban; Tomography, X-Ray Computed; Tyrosine | 2012 |
Upstream glycoprotein IIb/IIIa inhibitors for STEMI: use on-time or not at all?
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Emergency Medical Services; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2012 |
Acute myocardial infarction secondary to blunt chest trauma treated with thrombus aspiration.
Topics: Adult; Cardiac Catheterization; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Thoracic Injuries; Tirofiban; Tyrosine; Wounds, Nonpenetrating | 2012 |
Left main coronary artery thrombus resulting from combined protein C and S deficiency.
Topics: Adult; Coronary Angiography; Coronary Thrombosis; Electrocardiography; Fibrinolytic Agents; Humans; Male; Protein C Deficiency; Protein S Deficiency; Tirofiban; Tyrosine | 2012 |
Management of myocardial infarction related to in situ thrombosis.
Topics: Angina Pectoris; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Myocardial Infarction; Thrombectomy; Tirofiban; Tyrosine | 2013 |
A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention.
Topics: Abciximab; Antibodies, Monoclonal; Coronary Disease; Coronary Thrombosis; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Multivariate Analysis; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Dissolution of a huge spontaneous coronary artery thrombus with a new antiplatelet agent and coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Fibrinolytic Agents; Humans; Male; Tirofiban; Tyrosine | 2003 |
Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Statistics, Nonparametric; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Equipment Design; Female; Fibrinolytic Agents; Humans; Incidence; Intraoperative Care; Male; Middle Aged; Myocardium; Postoperative Complications; Taiwan; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Treatment of intracoronary thrombus using tirofiban in a patient with normal coronary arteries.
Topics: Angina, Unstable; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Fibrinolytic Agents; Humans; Male; Middle Aged; Tirofiban; Tyrosine | 2004 |
Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
Topics: Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recovery of Function; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine | 2004 |
An image of coronary thrombus mimicking dissection detected by intravascular ultrasound during functional evaluation of an intermediate lesion.
Topics: Aged; Anticoagulants; Aortic Dissection; Coronary Aneurysm; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Diagnosis, Differential; Fibrinolytic Agents; Heparin; Humans; Infusions, Intravenous; Male; Tirofiban; Tyrosine; Ultrasonography, Interventional; Whole Blood Coagulation Time | 2004 |
Combination of a high bolus dose of tirofiban with half-dose thrombolytics for the treatment of subacute stent thrombosis.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Myocardial Infarction; Risk Assessment; Stents; Tirofiban; Tyrosine; Vascular Patency | 2005 |
Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Animals; Coronary Thrombosis; Dogs; Integrin alphaVbeta3; Male; Models, Animal; Myocardial Infarction; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrimidines; Random Allocation; Tirofiban; Tyrosine | 2005 |
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Humans; Infusion Pumps; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Failure; Treatment Outcome; Tyrosine; Warfarin | 2006 |
Role of tirofiban in treatment of stent thrombosis.
Topics: Aged; Coronary Angiography; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Tyrosine | 2006 |
Acute coronary embolism after mitral valve replacement in a patient presenting with non-ST-segment elevation myocardial infarction.
Topics: Adult; Angina Pectoris; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Fibrinolytic Agents; Heart Conduction System; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2006 |
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Tirofiban; Tyrosine | 2007 |
Coronary embolism in a patient with mitral valve prosthesis: successful management with tirofiban and half-dose tissue-type plasminogen activator.
Topics: Coronary Thrombosis; Embolism; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 2007 |
Long term tirofiban infusion before percutaneous coronary intervention in patients with angiographically massive intracoronary thrombus.
Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Thrombosis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Statistics, Nonparametric; Tirofiban; Treatment Outcome; Tyrosine | 2008 |
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine | 1998 |
Tirofiban for cocaine-induced coronary artery thrombosis: a novel therapeutic approach.
Topics: Adult; Cocaine; Coronary Thrombosis; Fibrinolytic Agents; Humans; Male; Tirofiban; Tyrosine; Vasoconstrictor Agents | 1999 |
Adjunctive therapies in the cath lab. Intracoronary tirofiban infusion in a case with massive intracoronary thrombus.
Topics: Adult; Coronary Thrombosis; Humans; Male; Platelet Aggregation Inhibitors; Radiography; Tirofiban; Tyrosine | 2001 |
Adjunctive therapies in the cath lab. Use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Combined Modality Therapy; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Platelet Aggregation Inhibitors; Recombinant Proteins; Renal Insufficiency; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2001 |
Resolution of a spontaneous coronary artery thrombus with a new antiplatelet agent.
Topics: Coronary Angiography; Coronary Thrombosis; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2001 |
Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation.
Topics: Animals; Biopterins; Blood Platelets; Coronary Thrombosis; Cyclic GMP; Dogs; Enzyme Inhibitors; Hemodynamics; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; P-Selectin; Platelet Aggregation; Superoxides; Tyrosine | 2001 |
Images in cardiology. Glycoprotein IIb/IIIa induced coronary thrombolysis.
Topics: Adult; Anticoagulants; Coronary Thrombosis; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2002 |
Cost efficacy of platelet glycoprotein IIb/IIIa antagonists in clinical trials and clinical practice.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Thrombosis; Cost-Benefit Analysis; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Patterns, Physicians'; Tirofiban; Tyrosine | 2002 |